The Glu27 allele of the β2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertension

Journal of Hypertension

Volumn 22, Issue 11, 2004, Pages 2117-2122

  Iaccarino, Guido ^a   Lanni, Francesca ^a   Cipolletta, Ersilia ^a   Trimarco, Valentina ^a   Izzo, Raffaele ^a   Iovino, Gianni Luigi ^a   De Luca, Nicola ^a   Trimarco, Bruno ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cardiac hypertrophy; Genetics; Hypertension

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR;

ADULT; AGED; ALLELE; ANAMNESIS; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN; ULTRASOUND; ADOLESCENT; CARDIOMEGALY; ECHOGRAPHY; GENETIC PREDISPOSITION; GENETICS; HYPERLIPIDEMIA; MIDDLE AGED; RISK FACTOR;

ADOLESCENT; ADULT; AGED; CARDIOMEGALY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; RISK FACTORS;

EID: 7744225714     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200411000-00013     Document Type: Article

References (28)

1. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension, 2003. J Hypertens 2003; 21:1011-1053.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
3. Turner ST, Boerwinkle E. Genetics of hypertension, target-organ complications, and response to therapy. Circulation 2000; 102:IV40-IV45
4. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330:1041-1046.
5. Feinleib M, Garrison RJ, Fabsitz R, Christian JC, Hrubec Z, Borhani NO, et al. The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results. Am J Epidemiol 1977; 106:284-285.
6. Liggett SB. Molecular and genetic basis of beta2-adrenergic receptor function. J Allergy Clin Immunol 1999; 104:342-346.
7. Brodde OE, Buscher R, Tellkamp R, Radke J, Dhein S, Insel PA. Blunted cardiac responses to receptor activation in subjects with Thr164lle beta(2)-adrenoceptors. Circulation 2001; 103:1048-1050.
8. Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM, et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2001; 345:1030-1035.
9. Bray MS, Boerwinkle E. The role of beta(2)-adrenergic receptor variation in human hypertension. Curr Hypertens Rep 2000; 2:39-43.
10. Kotanko P, Binder A, Tasker J, DeFreitas P, Kamdar S, Clark AJ, et al. Essential hypertension in African Caribbean's associates with a variant of the beta2-adrenoceptor. Hypertension 1997; 30:773-776.
11. Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Timmermann B, et al. Beta-2 adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 1999; 33:1425-1430.
12. Bengtsson K, Orho-Melander M, Melander O, Lindblad U, Ranstam J, Rastam L, et al. Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension 2001; 37:1303-1308.
13. Tomaszewski M, Brain NJ, Charchar FJ, Wang WY, Lacka B, Padmanabahn S, et al. Essential hypertension and beta2-adrenergic receptor gene: linkage and association analysis. Hypertension 2002; 40:286-291.
14. Wagoner L, Craft L, Singh B, Suresh D, Zengel P, McGuire N, et al. Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. Circulation Research 2000; 86:834-840.
15. Liggett SB, Wagoner LE, Craft LL, Hornung RW, Hoit BD, McIntosh TC, et al. The lle164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 1998; 102:1534-1539.
16. Trimarco B, Ricciardelli B, De Luca N, De Simone A, Cuocolo A, Galva MD, et al. Participation of endogenous catecholamines in the regulation of left ventricular mass in progeny of hypertensive parents. Circulation 1985; 72:38-46.
17. Trimarco B, Wikstrand J. Regression of cardiovascular structural changes by antihypertensive treatment. Functional consequences and time course of reversal as judged from clinical studies. Hypertension 1984; 6:III150-III157
18. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21:821-848.
19. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55:613-618.
20. Grandi AM, Broggi R, Colombo S, Santillo R, Imperiale D, Bertolini A, et al. Left ventricular changes in isolated office hypertension: a blood pressure-matched comparison with normotension and sustained hypertension. Arch Intern Med 2001; 161:2677-2681.
21. Zanchetti A, Rosei EA, Dal Palu C, Leonetti G, Magnani B, Pessina A. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness. J Hypertens 1998; 16:1667-1676.
22. Large V, Hellstrom L, Reynisdottir S, Lonnqvist F, Eriksson P, Lannfelt L, et al. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest 1997; 100:3005-3013.
23. Busjahn A, Li GH, Faulhaber HD, Rosenthal M, Becker A, Jeschke E, et al. Beta-2 adrenergic receptor gene variations, blood pressure, and heart size in normal twins. Hypertension 2000; 35:555-560.
24. Ganau A, Devereux RB, Pickering TG, Roman MJ, Schnall PL, Santucci S, et al. Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation 1990; 81:25-36.
25. Mark AL, Kerber RE. Augmentation of cardiopulmonary baroreflex control of forearm vascular resistance in borderline hypertension. Hypertension 1982; 4:39-46.
26. Rosmond R, Ukkola O, Chagnon M, Bouchard C, Bjorntorp P. Polymorphisms of the beta2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men. J Intern Med 2000; 248:239-244.
27. Sakane N, Yoshida T, Umekawa T, Kogure A, Kondo M. Beta2-adrenoceptor gene polymorphism and obesity. Lancet 1999; 353:1976.
28. Macho-Azcarate T, Marti A, Gonzalez A, Martinez JA, Ibanez J. Gln27Glu polymorphism in the beta2 adrenergic receptor gene and lipid metabolism during exercise in obese women. Int J Obes Relat Metab Disord 2002; 26:1434-1441.